Global AI In Genomics Market Size study & Forecast, by Component (Hardware, Software, Services), By Technology (Machine Learning, Computer Vision), By Functionality (Genome Sequencing, Gene Editing, Others), By Application (Drug Discovery & Development, P

Global AI In Genomics Market Size study & Forecast, by Component (Hardware, Software, Services), By Technology (Machine Learning, Computer Vision), By Functionality (Genome Sequencing, Gene Editing, Others), By Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others), By End-use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others), and Regional Analysis, 2022-2029

Global AI In Genomics Market is valued at approximately USD 341.03 million in 2021 and is anticipated to grow with a healthy growth rate of more than 46.0% over the forecast period 2022-2029. Artificial intelligence (AI) is used in genomics to create computer systems that can carry out tasks such as mapping genomes. The structure, evolution, and function of genetic material are also explored with AI more quickly than with human participation. Although the primary goal of AI algorithms is to replicate human intelligence, clinical genomics is geared at performing genomic analysis, which phenotype-to-genotype correspondence, comprises variant calling, genome annotation, and genome annotation. Moreover, AI techniques can assist in immediately predicting DNA or protein structure that does not feature handcrafting. The increasing government investments, the surge in the adoption of AI in precision medicine, the reduction in cost and time for genome sequencing, and rising genomic datasets are the key factors that are fostering market growth across the globe.

Moreover, the rising investment in research of personalized medicine is also fueling the market demand at a substantial rate. As per Statista, in 2019, the global market for personalized medicine market was estimated to be worth around USD 1,980 billion, which is projected to reach USD 2,770 billion by the year 2022. Consequentially, the growing focus on the research of personalized medicine is associated with the growth of the AI In Genomics Market. In addition, the rising emphasis on developing human-aware AI systems, as well as the increasing advancement in the field of gene therapy are presenting various lucrative opportunities over the forecasting years. However, the dearth of skilled AI professionals and stringent regulatory framework are hindering market growth over the forecast period of 2022-2029.

The key regions considered for the Global AI In Genomics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing investment in R&D, rising advancements in AI-powered solutions for genomics, and the introduction of new software and tools for genomic data analysis. Whereas, Asia Pacific is expected to grow at the highest growth rate over the forecasting period. Factors such as the growing population, rising healthcare spending, increasing focus on precision medicine, and rapid advances in genomics technology are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
IBM Corporation
Microsoft Corporation
NVIDIA Corporation
DEEP GENOMICS
Data4Cure, Inc.
Freenome Holdings, Inc.
Thermo Fisher Scientific, Inc.
Illumina, Inc.
SOPHiA GENETICS
BenevolentAI
Recent Developments in the Market:
 In May 2021, the Adventist Church-run non-profit healthcare system AdventHealth and health intelligence company Sema4 entered into a partnership agreement. In this agreement, AdventHealth's genomic and clinical data are supposed to be combined using Sema4's software and tools. With investments in genomics research, genetic testing, counselling, and sequencing, AdventHealth was projected to increase its emphasis on genomics and personalised health as a result of this collaboration.
 In October 2020, NVIDIA announced a partnership with an AI-powered lab for the development of new drugs and vaccines. The GSK centre accessed more precise genetic and clinical data by combining AI technology, biological data, and contemporary computing platforms. Through NVIDIA Clara discovery, a collection of optimised computational drug discovery tools and frameworks, NVIDIA provided its experience in GPU optimisation and high-speed computational pipeline development.




Global AI In Genomics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Component, Technology, Functionality, Application, End-use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Component:
Hardware
Software
Services
By Technology:
Machine Learning
Computer Vision
By Functionality:
Genome Sequencing
Gene Editing
Others
By Application:
Drug Discovery & Development
Precision Medicine
Diagnostics
Others
By End-use:
Pharmaceutical and Biotech Companies
Healthcare Providers
Research Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World


Companies Mentioned
IBM Corporation
Microsoft Corporation
NVIDIA Corporation
DEEP GENOMICS
Data4Cure, Inc.
Freenome Holdings, Inc.
Thermo Fisher Scientific, Inc.
Illumina, Inc.
SOPHiA GENETICS
BenevolentAI

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.